HK Stock MarketDetailed Quotes

XUNFEIHEALTH (02506)

Watchlist
  • 67.500
  • -1.300-1.89%
Not Open Apr 24 16:01 CST
8.16BMarket Cap-113.83P/E (TTM)

XUNFEIHEALTH (02506) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Turnover
24.66%914.99M
30.26%298.55M
31.98%733.98M
17.82%229.21M
65.63%101.97M
17.86%556.13M
--324.34M
--194.53M
--61.56M
26.69%471.86M
Operating income
24.66%914.99M
30.26%298.55M
31.98%733.98M
17.82%229.21M
65.63%101.97M
17.86%556.13M
324.34M
194.53M
61.56M
26.69%471.86M
Cost of sales
-37.42%-453.35M
-33.96%-144.68M
-36.62%-329.9M
-15.92%-108.01M
-126.09%-49.69M
-0.12%-241.47M
---145.36M
---93.18M
---21.98M
-30.57%-241.19M
Operating expenses
-37.42%-453.35M
-33.96%-144.68M
-36.62%-329.9M
-15.92%-108.01M
-126.09%-49.69M
-0.12%-241.47M
-145.36M
-93.18M
-21.98M
-30.57%-241.19M
Gross profit
14.24%461.64M
26.96%153.87M
28.42%404.08M
19.58%121.2M
32.06%52.28M
36.41%314.65M
178.98M
101.36M
39.59M
22.87%230.67M
Selling expenses
-7.78%-207.04M
-16.70%-102.06M
-17.81%-192.1M
-27.23%-87.46M
-20.78%-33.12M
-1.99%-163.06M
---128.71M
---68.74M
---27.42M
-76.36%-159.87M
Administrative expenses
-5.91%-101.55M
-6.52%-47.4M
14.81%-95.89M
17.45%-44.5M
-13.63%-29.27M
-2.90%-112.56M
---81.31M
---53.9M
---25.76M
-57.74%-109.39M
Research and development expenses
9.79%-245.26M
15.36%-114.51M
-3.00%-271.89M
-6.50%-135.29M
-0.97%-62.92M
-9.27%-263.96M
---195.52M
---127.03M
---62.31M
-51.19%-241.58M
Impairment and provision
-165.03%-35.53M
62.13%-3.18M
-116.65%-13.4M
-139.51%-8.4M
-81.94%-4.3M
28.07%-6.19M
---3.04M
---3.51M
---2.36M
-1,269.75%-8.6M
-Other impairment is provision
-165.03%-35.53M
62.13%-3.18M
-116.65%-13.4M
-139.51%-8.4M
-81.94%-4.3M
28.07%-6.19M
---3.04M
---3.51M
---2.36M
-1,269.75%-8.6M
Special items of operating profit
1,288.06%46.04M
365.88%17.96M
-92.70%3.32M
-126.67%-6.76M
-22.86%8.4M
0.32%45.41M
--36.69M
--25.33M
--10.89M
83.94%45.27M
Operating profit
50.75%-81.69M
40.87%-95.32M
10.68%-165.88M
-27.44%-161.2M
-2.30%-68.93M
23.74%-185.7M
-192.91M
-126.49M
-67.38M
-125.32%-243.51M
Financing cost
-86.32%-11.44M
-130.91%-4.82M
-407.02%-6.14M
-4,990.24%-2.09M
-11,742.86%-829K
-105.25%-1.21M
---269K
---41K
---7K
79.62%-590K
Share of profits of associates
---2.86M
----
----
----
----
----
----
----
----
----
Adjustment items of  earning before tax
----
----
----
----
-3,417.29%-14.03M
----
---399K
----
---399K
----
Earning before tax
44.20%-95.99M
38.68%-100.13M
7.97%-172.02M
-29.05%-163.29M
-23.62%-83.79M
23.43%-186.92M
-193.58M
-126.53M
-67.78M
-119.97%-244.1M
Tax
-12.11%30.22M
-39.57%17.86M
5.17%34.38M
44.19%29.55M
26.06%12.93M
-7.93%32.69M
--23.63M
--20.5M
--10.26M
64.61%35.51M
After-tax profit from continuing operations
52.22%-65.77M
38.48%-82.28M
10.76%-137.64M
-26.13%-133.74M
-23.18%-70.86M
26.07%-154.22M
-169.94M
-106.04M
-57.53M
-133.33%-208.6M
Earning after tax
52.22%-65.77M
38.48%-82.28M
10.76%-137.64M
-26.13%-133.74M
-23.18%-70.86M
26.07%-154.22M
-169.94M
-106.04M
-57.53M
-133.33%-208.6M
Minority profit
80.56%-979K
-100.49%-8.19M
46.32%-5.04M
52.07%-4.09M
63.43%-1.8M
51.12%-9.38M
---11.37M
---8.52M
---4.93M
-237.11%-19.2M
Profit attributable to shareholders
51.14%-64.79M
42.86%-74.09M
8.45%-132.6M
-32.96%-129.65M
-31.29%-69.06M
23.53%-144.84M
-158.57M
-97.51M
-52.6M
-126.27%-189.4M
Basic earnings per share
53.45%-0.54
46.49%-0.61
10.77%-1.16
-29.55%-1.14
-29.79%-0.61
23.98%-1.3
-1.43
-0.88
-0.47
-90.00%-1.71
Diluted earnings per share
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
Deloitte Touche Tohmatsu会计师事务所
--
Deloitte Touche Tohmatsu会计师事务所
--
--
Deloitte Touche Tohmatsu会计师事务所
--
--
--
Deloitte Touche Tohmatsu会计师事务所
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Turnover 24.66%914.99M30.26%298.55M31.98%733.98M17.82%229.21M65.63%101.97M17.86%556.13M--324.34M--194.53M--61.56M26.69%471.86M
Operating income 24.66%914.99M30.26%298.55M31.98%733.98M17.82%229.21M65.63%101.97M17.86%556.13M324.34M194.53M61.56M26.69%471.86M
Cost of sales -37.42%-453.35M-33.96%-144.68M-36.62%-329.9M-15.92%-108.01M-126.09%-49.69M-0.12%-241.47M---145.36M---93.18M---21.98M-30.57%-241.19M
Operating expenses -37.42%-453.35M-33.96%-144.68M-36.62%-329.9M-15.92%-108.01M-126.09%-49.69M-0.12%-241.47M-145.36M-93.18M-21.98M-30.57%-241.19M
Gross profit 14.24%461.64M26.96%153.87M28.42%404.08M19.58%121.2M32.06%52.28M36.41%314.65M178.98M101.36M39.59M22.87%230.67M
Selling expenses -7.78%-207.04M-16.70%-102.06M-17.81%-192.1M-27.23%-87.46M-20.78%-33.12M-1.99%-163.06M---128.71M---68.74M---27.42M-76.36%-159.87M
Administrative expenses -5.91%-101.55M-6.52%-47.4M14.81%-95.89M17.45%-44.5M-13.63%-29.27M-2.90%-112.56M---81.31M---53.9M---25.76M-57.74%-109.39M
Research and development expenses 9.79%-245.26M15.36%-114.51M-3.00%-271.89M-6.50%-135.29M-0.97%-62.92M-9.27%-263.96M---195.52M---127.03M---62.31M-51.19%-241.58M
Impairment and provision -165.03%-35.53M62.13%-3.18M-116.65%-13.4M-139.51%-8.4M-81.94%-4.3M28.07%-6.19M---3.04M---3.51M---2.36M-1,269.75%-8.6M
-Other impairment is provision -165.03%-35.53M62.13%-3.18M-116.65%-13.4M-139.51%-8.4M-81.94%-4.3M28.07%-6.19M---3.04M---3.51M---2.36M-1,269.75%-8.6M
Special items of operating profit 1,288.06%46.04M365.88%17.96M-92.70%3.32M-126.67%-6.76M-22.86%8.4M0.32%45.41M--36.69M--25.33M--10.89M83.94%45.27M
Operating profit 50.75%-81.69M40.87%-95.32M10.68%-165.88M-27.44%-161.2M-2.30%-68.93M23.74%-185.7M-192.91M-126.49M-67.38M-125.32%-243.51M
Financing cost -86.32%-11.44M-130.91%-4.82M-407.02%-6.14M-4,990.24%-2.09M-11,742.86%-829K-105.25%-1.21M---269K---41K---7K79.62%-590K
Share of profits of associates ---2.86M------------------------------------
Adjustment items of  earning before tax -----------------3,417.29%-14.03M-------399K-------399K----
Earning before tax 44.20%-95.99M38.68%-100.13M7.97%-172.02M-29.05%-163.29M-23.62%-83.79M23.43%-186.92M-193.58M-126.53M-67.78M-119.97%-244.1M
Tax -12.11%30.22M-39.57%17.86M5.17%34.38M44.19%29.55M26.06%12.93M-7.93%32.69M--23.63M--20.5M--10.26M64.61%35.51M
After-tax profit from continuing operations 52.22%-65.77M38.48%-82.28M10.76%-137.64M-26.13%-133.74M-23.18%-70.86M26.07%-154.22M-169.94M-106.04M-57.53M-133.33%-208.6M
Earning after tax 52.22%-65.77M38.48%-82.28M10.76%-137.64M-26.13%-133.74M-23.18%-70.86M26.07%-154.22M-169.94M-106.04M-57.53M-133.33%-208.6M
Minority profit 80.56%-979K-100.49%-8.19M46.32%-5.04M52.07%-4.09M63.43%-1.8M51.12%-9.38M---11.37M---8.52M---4.93M-237.11%-19.2M
Profit attributable to shareholders 51.14%-64.79M42.86%-74.09M8.45%-132.6M-32.96%-129.65M-31.29%-69.06M23.53%-144.84M-158.57M-97.51M-52.6M-126.27%-189.4M
Basic earnings per share 53.45%-0.5446.49%-0.6110.77%-1.16-29.55%-1.14-29.79%-0.6123.98%-1.3-1.43-0.88-0.47-90.00%-1.71
Diluted earnings per share
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion----Unqualified Opinion------Unqualified Opinion
Auditor Deloitte Touche Tohmatsu会计师事务所--Deloitte Touche Tohmatsu会计师事务所----Deloitte Touche Tohmatsu会计师事务所------Deloitte Touche Tohmatsu会计师事务所

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More